Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

NCT01073644 · clinicaltrials.gov ↗
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued due to poor recruitment on 18th April 2013. There were no safety concerns that led to the decision to terminate.

Conditions

Interventions

Sponsor

Pfizer